SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Mac who wrote ()1/12/2000 2:03:00 PM
From: art slott  Read Replies (1) of 413
 
Leveling the playing field

At this time, TrueVision utilizes an excimer laser developed by VISX (VISX), which until recently had a virtual monopoly on the laser equipment market. Last year, rival Japanese laser manufacturer Nidek filed and won an antitrust lawsuit against VISX, sending the heavyweight's stock tumbling. With the judgment, the playing field will dramatically change for laser centers such as TrueVision. Up until now, VISX was the only manufacturer available, and therefore set its price accordingly. Those purchasing VISX equipment not only had to pay a hefty one-time fee, but also had to kick back $250 to VISX for each procedure performed on its machines. No longer. With competitors such as Nidek anxious to dive into the market with no recurring procedure fees, steep prices will become a thing of the past.

ragingbull.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News